ENT.AX stock up 25.00% to A$0.005 at ASX close 25 Feb 2026: outlook check
ENT.AX stock rose 25.00% to A$0.005 at ASX close 25 Feb 2026. Low volume and Meyka AI forecast show modest near-term upside.
ENT.AX stock rose 25.00% to A$0.005 at ASX close 25 Feb 2026. Low volume and Meyka AI forecast show modest near-term upside.
Trump 401k plan from the State of the Union could boost stock market flows into low‑cost index funds, supporting ^GSPC, while tariff policy risk on a 10% base rate clouds margins. Singapore investors:
MOTE stock trades at $28.78 pre-market; short-term oversold bounce setup and Meyka AI forecast project upside
Oppenheimer maintained Outperform on Oppenheimer Holdings Inc. OPY analyst rating held on Feb 24, 2026
AKI.NS stock fell 18.36% after hours to INR 4.98 on 25 Feb 2026; read analysis, grade and forecasts
Intraday volume spike for MA13.PA stock on EURONEXT; liquidity and NAV moves suggest trading signal
Claude Code and new Anthropic Claude plugins tied to Microsoft Excel integration lifted software stocks and buoyed the Nasdaq-100. What Singapore investors should watch now.
Intraday volume spike lifts SCR.SW stock to CHF25.90; high relative volume ahead of earnings on 04 Mar 2026
6696.T stock jumps to JPY 420.00 on heavy volume; short-term momentum and analyst-grade outlook explained
Volume spike for 83012.HK stock on HKSE; price HKD 17.58 and rel vol 187.50. Quick analysis and forecast